The NTMir R&D (Research and Development) Pipeline features clinical trials and studies for drugs and devices in development to treat pulmonary nontuberculous mycobacterial infections, bronchiectasis, or related comorbid diseases and infectious pathogens.
Studies are categorized as Therapeutic or Observational, and listed as Pre-Clinical, Phase 1, Phase 2, Phase 3, and Approved. When a sponsor decides not to pursue further development, the study is removed from the website.
To have your clinical trial or study listed on the R&D Pipeline, direct inquiries and information to firstname.lastname@example.org. Listing information should include screening criteria, contact information, and links you wish to include to published data or presentations.